WASHINGTON, May 9, 2024 — A federal grand jury has indicted Done Global, a telehealth company, accusing it of orchestrating a $100 million scheme to illegally distribute Adderall and other medications used to treat attention-deficit/hyperactivity disorder (ADHD) over the internet. It’s a startling accusation that raises serious questions about the rapidly expanding world of online prescriptions.
Telehealth Giant Faces Serious Allegations
Table of Contents
The indictment alleges Done Global facilitated the unlawful distribution of controlled substances, capitalizing on the increasing demand for ADHD medications.
- The indictment alleges Done Global engaged in a $100 million scheme.
- The scheme involved the illegal distribution of Adderall and other ADHD medications.
- Prosecutors claim the company exploited telehealth regulations.
- Four individuals associated with Done Global have been charged.
The Justice Department alleges that Done Global, along with four individuals—identified as Ragnar Lifthorsson, 49; Brittney Lofthouse, 30; Thomas Koenig, 39; and Wade Kraus, 41— conspired to defraud patients and healthcare insurers. The core of the alleged scheme involved minimal medical evaluations before prescribing controlled substances, effectively bypassing standard safeguards.
How the Scheme Allegedly Worked
According to prosecutors, Done Global incentivized its prescribers to issue prescriptions quickly and in high volumes, prioritizing profits over patient safety. The company allegedly used marketing tactics to attract patients seeking easy access to ADHD medications, often without a comprehensive medical assessment. This practice, authorities say, led to the inappropriate and illegal distribution of drugs like Adderall, a Schedule II controlled substance.
The indictment details how Done Global allegedly profited from the scheme through inflated billing practices and by attracting a large patient base willing to pay for convenient access to medication. Prosecutors claim the company knowingly violated regulations governing the prescription of controlled substances via telehealth.
Potential Consequences for Those Involved
If convicted, the four individuals face significant prison sentences. The charges include conspiracy to commit healthcare fraud and illegal distribution of controlled substances. The maximum penalties vary depending on the specific charges, but could amount to decades in prison. The indictment also seeks forfeiture of assets obtained through the alleged illegal activities.
Is telehealth regulation keeping pace with innovation? The Done Global case highlights the challenges of regulating the rapidly evolving telehealth industry, where convenience and accessibility must be balanced with patient safety and adherence to medical standards.
The Justice Department has been increasingly focused on cracking down on fraudulent practices within the telehealth industry, particularly those involving the prescription of controlled substances. This case serves as a stark warning to other telehealth companies about the importance of complying with all applicable laws and regulations.
